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Any effort to bring new light on the management of older
patients with cancer should be welcomed and considered
with interest. A large amount of evidence has now been
gathered, proving signiﬁcant delays in cancer detection,
under-staging, and substandard treatment of this age sub-
group, resulting in inferior survival. We have no standard of
care and no evidence-based guidelines available for this age
group because it has regularly been excluded from clinical
trials: our knowledge on cancer management simply has
never been validated in the older subsetting.
Onenoteofconcernrestsonthefactthatworld-renowned
centers of excellence omit data on frailty, hence failing to
identify which patients have been involved in their stud-
ies.
1–3Severaleditorialnotesalsolackthesameinformation.
Reports from these researchers only include age and ASA,
with no reference to comorbidities, frailty, or performance
status.
4–6 Consequently, these series most frequently pres-
ent highly biased ﬁndings retrieved from super-selected
cohorts: it is only the superﬁt onco-geriatric patient that
reaches surgical theater. This implies that all considerations
and conclusions cannot be applied to the overall geriatric
population.
It would be totally unacceptable to present series without
clearly stating patients’ stage. The TNM staging system is
fundamental in drafting treatment plans, comparing series,
testingnewdrugs,draftingguideline,consentingpatients,etc.
Inaverysimilarway,wearenolongerjustiﬁedtopresent
series of older patients without frailty data. Anagraphic age
is not sufﬁcient to characterize these patients; after a decade
of discussion with geriatricians, it is now clear that Com-
prehensive Geriatric Assessment is the most accurate
instrument. Unfortunately, this is not adequate for our busy
clinicalpracticebecauseitrequiresseveralhoursperpatient.
For this reason, quicker tools have been tested and vali-
dated.
7–9 These tools are capable of identifying those frail
individuals who should be referred to special geriatric care
before surgical management.
A modern approach should take advantage of the
few available days/weeks before elective cancer surgery is
planned to correct anemia, dehydration, malnourishment,
and depression; optimizing the patient’s conditions, as high-
lightedbyfrailtyassessmenttools,willeventuallyreducethe
occurrence of operative complications. The use of neoad-
juvant chemoradiation for several malignancies offers an
excellent window of opportunity to this purpose.
Interestingly, present research is moving one step for-
ward and the already available tools are being tested
against quicker ones, only taking 3–5 min to administer,
hence being informative and appropriate to use in our busy
routine.
10
We entirely agree with the authors statement that the
‘‘involvement of physicians and afﬁliated caregivers
equipped to evaluate and apply multidisciplinary treatment
programs tailored to preexisting comorbidities rather than
age per se may hold the best promise for improved prog-
nosis in this challenging clinical circumstance.’’
6 We need
to bring this into clinical practice as well as scientiﬁc
reporting. The lack of frailty data makes the conclusions
meaningless.
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